Pre-seed

Building a pioneering indigenous silk biomaterials platform.

SilkMatrix™ transforms silk fibroin and sericin into bioresorbable implants and matrices for bone repair, dental regeneration, wound care and tissue engineering.

Investor Brief → Explore the Science
Bone-like
Founder’s silk-cryogel strength vs. human bone
10+ Years
Founder R&D in biomedical science
ISO 10993
Founder is a biocompatibility expert
INSERM
Marie Curie research lineage
IIT Kanpur
Founder’s silk research pedigree
The Thesis

Silk is one of medicine’s most proven biomaterials — yet its advanced forms remain largely uncommercialised.

Silk sutures have been trusted in surgery for over a century. But regenerated silk fibroin and sericin — tunable, bioresorbable, and biocompatible — are only beginning to reach the clinic. SilkMatrix is built to close that gap with an indigenous, scalable platform.

Bioresorbable by design

Silk-based implants can be tuned to provide mechanical support, then safely resorb — avoiding the second surgeries and stress‑shielding associated with permanent metal hardware.

A platform, not a product

One core material science enables many devices — fixation, dental membranes, wound matrices, scaffolds and coatings — multiplying shots on goal from a single R&D base.

Made in India, for the world

India is a leading producer of silk. SilkMatrix aims to convert that raw-material advantage into high-value, indigenous regenerative medical devices.

Microscope view of a silk-fibroin scaffold showing a honeycomb of interconnected pores
The SilkMatrix™ Platform

A single silk biomaterials engine behind every product.

Our platform processes silk fibroin and sericin into purified, controllable biomaterials — films, gels, porous scaffolds, coatings and solid forms — with tunable strength and resorption profiles.

  • ✓Tunable mechanicsFrom soft matrices to load-bearing fixation forms.
  • ✓Controlled bioresorptionDegradation matched to the healing timeline of the target tissue.
  • ✓Biocompatible & standards-alignedDesigned toward ISO 10993 biological evaluation from day one.
How it works →
Amber-coloured bioresorbable silk-fibroin bone-fixation plate and screw on a soft ivory surface
Lead Program · SilkMatrix Osteo™

A bioresorbable bone fixation system.

Our first focused program develops a silk-based screw and plate system for fracture fixation — verified through mechanical testing, ISO 10993 biological evaluation, and small- and large-animal preclinical studies.

It is the most de-risked path to first revenue and clinical credibility for the broader platform.

Inside the lead program →
The Founder Advantage

The founder didn’t just find this idea — he proved the science with his own hands.

The lead program is grounded in the founder’s own research, where he demonstrated that a silk-fibroin cryogel can meet bone-fixation requirements, with compressive strength comparable to human bone. He then became an ISO 10993 biocompatibility expert — the exact skill needed to turn proven science into an approved device. SilkMatrix builds its own, independently-owned IP from there.

Proved the science

Demonstrated a silk-cryogel construct with bone-like strength, meeting bone-fixation requirements in his own graduate research.

ISO 10993 expert

Runs a regulatory practice preparing biological evaluations for EU MDR, FDA & CDSCO.

Marie Curie Fellow

Implant biocompatibility research at INSERM, France (EU Horizon 2020).

Published scientist

10+ years in biomaterials & cell biology; peer-reviewed author (Elsevier, Wiley).

Meet the Founder →
Platform Pipeline

Five product lines from one material science.

A staged pipeline: prove the platform with the lead fixation program, then expand into adjacent high-value regenerative markets.

Lead Program

SilkMatrix Osteo™

Bioresorbable bone fixation — screws & plates.

In Development

SilkMatrix Scaffold™

Porous scaffolds for soft & hard tissue engineering.

In Development

SilkMatrix Wound™

Advanced wound-healing matrices & dressings.

Concept

SilkMatrix Dental™

Guided bone regeneration & dental membranes.

Concept

SilkMatrix Coat™

Bioactive silk coatings for implant surfaces.

Funding Strategy

A disciplined, two-phase plan built around clear decision gates.

We structure investment so capital is deployed against evidence — each phase ends in an explicit Go / No-Go decision before the next is committed.

Phase 1

R&D Validation

Prove reproducibility, formulation, early safety, and IP / legal readiness.

  • Material reproducibility & formulation
  • Early biocompatibility signals
  • IP filing & legal foundation
Ends in Go / No-Go decision
Phase 2

Product Development & Preclinical

Develop the screw / plate system, verify mechanics, and complete biological & animal validation.

  • Device design & mechanical verification
  • ISO 10993 biological evaluation
  • Small- & large-animal studies
Gate to manufacturing, QMS & clinical
See the investor brief →
Investor Engagement

Partner with us at the foundation.

We are engaging a select group of strategic investors and technical advisors to build the indigenous silk biomaterials platform. Request the full confidential brief.

Request Investor Brief Contact the Founder